Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.
Criteria & Qualifications:
• Is at least 16 years of age or older.
• Is willing to provide medical records.
Compensation:
Contact us for more information
| Patient Population | |
|---|---|
| Study Status | Active |
NASH, often a silent liver condition, typically remains undetected until it becomes advanced. It begins with an accumulation of fat in the liver and can progress to significant liver injury. Taking early measures is crucial to curb its severity.
Criteria & Qualifications:Â
• Participants need to be aged 18 or older.
• Must have a diagnosis of Fatty Liver Disease.
Compensation:
Contact us for more information
Ulcerative Colitis causes inflammation and ulcers in the colon, resulting in abdominal discomfort. This study evaluates a new treatment's efficacy and safety for those with moderate to severe conditions. It targets individuals unsatisfied with or affected by current therapies' side effects.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation:
Contact Us For More information
NASH is a liver disease with inflammation and damage from fat buildup. If you have NASH, consider participating in our study to help find new treatments.
Criteria & Qualifications:Â
• Must be 18 years or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation:
Contact us for more information
Coming Soon!
This study investigates the progression of Chronic Heart Failure and tests new treatments aimed at improving heart function and quality of life in patients experiencing heart failure symptoms.
Criteria & Qualifications:
• More than 18 years old.
• Willing to participate in the study.
• Currently experiencing symptoms of heart failure.
Compensation:
Contact us for more information